Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1734 of 6351
-
AI-Powered stethoscope could save newborns from missed heart defects
Diagnosis Recruiting nowNeonatal screening procedures for potentially life-threatening congenital cardiovascular diseases (i.e., duct-dependent systemic or pulmonary circulation), currently implemented at the national level, rely primarily on cardiovascular physical examination performed by a neonatolog…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Nerve-Zapping showdown: which procedure best stops a runny nose?
Disease control By invitation onlyThe goal of this clinical trial is to learn which procedural intervention most effectively reduces symptoms of chronic rhinitis (non-allergic rhinitis) in adult patients (18 years and older). The main questions it aims to answer are: * Which procedural intervention leads to the …
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for stem cell transplant patients: simpler drug combo may reduce severe side effects
Disease control Recruiting nowGraft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-CSH). Recently, in the context of semi-identical (=haploidentical) HLA donors, but also of compatible HLA donors, the use of cyclophosphamide (CY) administered in…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New pill aims to tame Crohn's Flare-Ups
Disease control Recruiting nowThis is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 3 active dose regimens of MORF-057 in adult study participants with moderately to severely active Crohn's disease (CD).
Phase 2 • Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New antibiotic cocktail aims to delay preterm birth after water breaks
Disease control Recruiting nowTo conduct an unblinded pragmatic randomized controlled trial (pRCT) "Improvement of PPROM Management with Prophylactic Antimicrobial Therapy (iPROMPT)" of a seven-day course of ceftriaxone, clarithromycin, and metronidazole versus the current standard of care of a seven-day cour…
Phase 4 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Long COVID exercise breakthrough? new study tests ways to boost energy
Symptom relief CompletedThis is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key …
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New shot could shrink nasal polyps and ease breathing
Disease control CompletedThis is a parallel, Phase 2, 2-arm, multicenter, randomized, double-blind, placebo-controlled, proof-of-concept study for treatment of CRSwNP. The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with subcutaneous lunsekimig in adult pa…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a common drug help cancer patients regain appetite?
Symptom relief Recruiting nowThis phase II trial tests how well olanzapine works in managing cancer cachexia in patients experiencing esophagogastric, hepatopancreaticobiliary, colorectal, or lung cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the b…
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New drug BMS-986470 enters human trials for sickle cell disease
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics, pH and food effect, and preliminary efficacy of BMS-986470 in healthy volunteers and participants with sickle cell disease.
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New diabetes shot every two weeks could rival weekly drug
Disease control OngoingThe aim of the study is to compare the efficacy and safety of two JY09 doses versus dulaglutide as add-on therapy to metformin in participants with type 2 diabetes mellitus (T2DM)
Phase 3 • Sponsor: Beijing Dongfang Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:59 UTC
-
Can a common breast cancer drug slow uterine sarcoma?
Disease control Recruiting nowThis is a clinical trial to test letrozole in patients with uterine leiomyosarcoma. The main question is will treatment with letrozole extend progression-free survival in patients. Patients will receive 2/5 mg of letrozole daily.
Phase 2 • Sponsor: GOG Foundation • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could a synthetic peptide offer a new way to tackle Parkinson's?
Disease control Recruiting nowPhase I a/b SAD/MAD study to evaluate safety and tolerability of LBT-3627 in both healthy volunteers and Parkinson's patients.
Phase 1 • Sponsor: Longevity Biotech Australia Pty Ltd (subsidiary) • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug aims to shield heart muscle after major attack
Disease control Recruiting nowThis is an exploratory, randomized, double-blind, multicentre, placebo-controlled study of RTP-026. The study population will consist of men and women with documented evidence of ST-elevation myocardial infarction (STEMI) referred to primary Percutaneous Coronary Intervention (P…
Phase 2 • Sponsor: ResoTher Pharma • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Brain zap may stop chemo nerve damage
Prevention Recruiting nowCohort 1: To track the onset and progression of a condition called chemotherapy-induced peripheral neuropathy (CIPN). Cohort 2: To track the onset and progression of a condition called chemotherapy-induced peripheral neuropathy (CIPN) and to test a certain type of experimental n…
Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
Gut bacteria could help revive immunotherapy in lung cancer
Disease control Recruiting nowAs treatment options are limited following progression on anti PD-(L)1 and platinum-based chemotherapy, we propose this trial for patients who have failed to respond or have shown intolerance to standard therapies or for whom no appropriate therapies are known to provide clinical…
Phase 1/2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can ruxolitinib stop a deadly transplant complication in kids?
Disease control Recruiting nowThis phase II trial tests how well ruxolitinib with tacrolimus and methotrexate work to prevent the development of graft versus host disease in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplant for acute myeloid leukemia, acute lymphoblastic l…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New mRNA vaccine trial hopes to stop pancreatic cancer return
Disease control Recruiting nowThis study primarily aims to assess the safety and tolerability of XP-004 personalized mRNA vaccines encoding tumor neoantigens combined with PD-1 inhibitor as adjuvant therapy for chemotherapy-intolerant patients following radical pancreatic cancer resection. Secondary objectiv…
Early phase 1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Hidden lung disease? online quiz could lead to Life-Changing treatment
Diagnosis Recruiting nowOur research group has found that Canadians with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) have increased respiratory symptoms and worse health-related quality of life. The investigators recently developed and validated an on-line questionnaire to accura…
Sponsor: Ottawa Hospital Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Hope for liver disease: new drug trial targets PBC symptoms
Disease control OngoingOpen-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
Phase 3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Cholesterol drug may supercharge immune cells against prostate cancer
Disease control Recruiting nowTo test the hypothesis that intensive cholesterol lowering (iCL) therapy has anti-tumor immune modulating activity, the investigators will conduct an open-label, single-arm phase II trial in prostate cancer patients who are in active surveillance and undergoing a planned surveill…
Phase 2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC